Suppr超能文献

脓毒症患者的抗生素治疗方法。

An approach to antibiotic treatment in patients with sepsis.

作者信息

Martínez María Luisa, Plata-Menchaca Erika P, Ruiz-Rodríguez Juan Carlos, Ferrer Ricard

机构信息

Department of Intensive Care, Hospital Universitario General de Catalunya, Barcelona, Spain.

Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

出版信息

J Thorac Dis. 2020 Mar;12(3):1007-1021. doi: 10.21037/jtd.2020.01.47.

Abstract

Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, which is time-dependent and associated with unacceptably high mortality. Thus, when treating suspicious or confirmed cases of sepsis, clinicians must initiate broad-spectrum antimicrobials within the first hour of diagnosis. Optimizing antibiotic use is essential to ensure successful outcomes and to reduce adverse antibiotic effects, as well as preventing drug resistance. All likely pathogens involved should be considered to provide an appropriate antibiotic coverage. Clinicians must investigate on the previous risk of multidrug-resistant (MDR) pathogens, and the principle of individualized dosing should replace the principle of standard dosing. The loading dose is an initial higher dose of an antibiotic for all patients, yet an individualized treatment approach for further doses should be implemented according to pharmacokinetics (PK)/pharmacodynamics (PD) and the presence of renal/liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring (TDM) can help to achieve therapeutic levels of antimicrobials. Reevaluation of duration and appropriateness of treatment at regular intervals are also necessary. De-escalation and shortened courses of antimicrobials must be considered for most patients, except in some justified circumstances. Leadership, teamwork, antimicrobial stewardship (AS) frameworks, guideline's recommendations on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients' quality of care.

摘要

脓毒症是一种医疗急症,因宿主对感染的反应失调而危及生命,具有时间依赖性且死亡率高得令人难以接受。因此,在治疗可疑或确诊的脓毒症病例时,临床医生必须在诊断后的第一小时内开始使用广谱抗菌药物。优化抗生素的使用对于确保治疗成功、减少抗生素不良反应以及预防耐药性至关重要。应考虑所有可能涉及的病原体,以提供适当的抗生素覆盖范围。临床医生必须调查先前存在的多重耐药(MDR)病原体风险,个体化给药原则应取代标准给药原则。负荷剂量是所有患者初始使用的较高剂量抗生素,但后续剂量应根据药代动力学(PK)/药效学(PD)以及肾/肝功能障碍的情况采用个体化治疗方法。β-内酰胺类药物的延长或持续输注以及治疗药物监测(TDM)有助于达到抗菌药物的治疗水平。定期重新评估治疗的持续时间和适当性也很有必要。除了某些合理的情况外,大多数患者都必须考虑抗菌药物的降阶梯治疗和缩短疗程。领导力、团队合作、抗菌药物管理(AS)框架、指南关于最佳治疗持续时间、降阶梯治疗的建议以及新型诊断管理方法将有助于我们提高患者的护理质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验